{"categories":["\u773c\u75c5\u5909"],"provider_url":"https://hatena.blog","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fsakurasasuke.hatenadiary.org%2Fentry%2F20121216%2F1355654430\" title=\"\u5931\u660e\u306e\u5371\u967a\u6027\u306e\u3042\u308b\u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u75c5\u30d6\u30c9\u30a6\u819c\u708e\u306b\u5bfe\u3059\u308b\u785d\u5b50\u4f53\u5185\u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6\u6ce8\u5c04\uff1a\u60a3\u800515\u540d\u306b\u5bfe\u3059\u308b\u30d1\u30a4\u30ed\u30c3\u30c8\u30fb\u30b9\u30bf\u30c7\u30a3 - \u533b\u8005\u3068\u3057\u3066\u30fb\u60a3\u8005\u3068\u3057\u3066\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","blog_url":"https://sakurasasuke.hatenadiary.org/","type":"rich","author_url":"https://blog.hatena.ne.jp/sakurasasuke/","width":"100%","version":"1.0","author_name":"sakurasasuke","height":"190","published":"2012-12-16 19:40:30","blog_title":"\u533b\u8005\u3068\u3057\u3066\u30fb\u60a3\u8005\u3068\u3057\u3066","description":"\u51fa\u5178 \u30a2\u30e1\u30ea\u30ab\u773c\u79d1\u5b66\u4f1a\u96d1\u8a8c2012\u5e749\u6708\u53f7\u3088\u308a Am J Ophthalmol. 2012 Sep;154(3):534-541.e1. doi: 10.1016/j.ajo.2012.03.035. Epub 2012 Jul 11. Intravitreal infliximab for sight-threatening relapsing uveitis in Behcet disease: a pilot study in 15 patients. Markomichelakis N, Delicha E, Masselos S, Sfikakis PP. Ocular Inflam\u2026","provider_name":"Hatena Blog","image_url":null,"title":"\u5931\u660e\u306e\u5371\u967a\u6027\u306e\u3042\u308b\u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u75c5\u30d6\u30c9\u30a6\u819c\u708e\u306b\u5bfe\u3059\u308b\u785d\u5b50\u4f53\u5185\u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6\u6ce8\u5c04\uff1a\u60a3\u800515\u540d\u306b\u5bfe\u3059\u308b\u30d1\u30a4\u30ed\u30c3\u30c8\u30fb\u30b9\u30bf\u30c7\u30a3","url":"https://sakurasasuke.hatenadiary.org/entry/20121216/1355654430"}